Cameroun's Pharmaceutical Industry Expands to 19 Production Units

Since 2020, Cameroon has seen a significant increase in its pharmaceutical production capacity, with the number of local production units rising from 7 to 19. This expansion reflects a growing commitment to enhance local manufacturing capabilities in the pharmaceutical sector, as indicated by recent reports. The increase in production units is accompanied by the approval of 239 drug references, showcasing a broader range of locally manufactured medicines.

Despite the increase in production units, local pharmaceutical products currently cover only about 15% of the National Essential Medicines List. This indicates that while progress has been made, there remains a significant gap in meeting the country's overall pharmaceutical needs. Furthermore, local production accounts for less than 5% of the total consumption requirements, underscoring the challenges faced by the industry.

On August 24, 2026, during a meeting in Addis Ababa, Cameroon emphasized its commitment to strengthening local pharmaceutical production and regulatory frameworks. This advocacy is part of a broader strategy to enhance the country's self-sufficiency in medicine manufacturing. The government aims to create a more robust local industry that can better meet the healthcare needs of its population.

The push for increased local production is seen as crucial for improving access to essential medicines and reducing dependency on imports. By fostering a stronger local pharmaceutical industry, Cameroon hopes to address the existing gaps in medicine availability and ensure that more citizens can access necessary treatments.